Last reviewed · How we verify
NCT04489277
Silent Brain Infarction After Endovascular Arch Procedures
trial testing Endovascular Arch Procedures in Aortic Arch Aneurysm in 91 participants. Completed in 31 January 2020.
31 January 2020
Quick facts
| Lead sponsor | Medical University of Vienna |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 91 |
| Start date | 1 September 2018 |
| Primary completion | 31 January 2020 |
| Estimated completion | 31 January 2020 |
| Sites | 2 locations across France, Germany |
Drugs / interventions tested
- Endovascular Arch Procedures
Conditions studied
- Aortic Arch Aneurysm — all drugs for Aortic Arch Aneurysm →
Sponsor
Medical University of Vienna
Who can join
Adults 18 to 100, any sex, with Aortic Arch Aneurysm. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is the largest study to evaluate incidence and distribution of silent cerebral infarction (SBI) following endovascular repair for disease of the aortic arch. Also, it is the first cohort to include total endovascular arch repair and devices flushed with carbon dioxide (CO2) to prevent gaseous cerebral embolization.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Silent Brain Infarction After Endovascular Arch Procedures: Preliminary Results from the STEP Registry.
Charbonneau P, Kölbel T, Rohlffs F, Eilenberg W, et al · · 2021 · cited 29× · PMID 33358103 · DOI 10.1016/j.ejvs.2020.11.021
Verify or expand the search:
- PubMed search for NCT04489277
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Aortic Arch Aneurysm
Currently open trials in the same condition.
- NCT06385379 — Guo's Aortic Arch Reconstruction: A Multicenter, Prospective Study of the Novel WeFlow-Tribranch System (GENIUS Study) · NA · recruiting
- NCT06520774 — Concave Supra-arch Branched Stent-Graft System for Endovascular Treatment of Aortic Arch Diseases · NA · recruiting
- NCT05530304 — Outcome of a Triple Inner Branched Aortic Arch Stentgraft. A Prospective, Multicenter Registry. · recruiting
- NCT04765592 — Guo's Aortic Arch Reconstruction :The Prospective ,Multiple Center Study About the Safety and Efficacy of WeFlow-Arch Mo · NA · active not recruiting
Other Medical University of Vienna trials
Trials by the same sponsor.
- NCT07473401 — Retinal Oxygen Metabolism in Children With Myopia · not yet recruiting
- NCT07511400 — The Role of NaV1.8 in Human Pain Models · EARLY_PHASE1 · not yet recruiting
- NCT07516990 — Intramuscular Injection of Mashed Parathyroid Tissue Into a Forearm During Thyroid Surgery to Prevent Permanent Postoper · NA · recruiting
- NCT07496437 — Is Cross-linked Hyaluronic Acid a Biologic Alternative for Alveolar Ridge Preservation? · NA · not yet recruiting
- NCT07290712 — Post-Intensive Care Syndrome - Multicentre Prospective Registry Database of the DACH Region · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04489277 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical University of Vienna
- Last refreshed: 6 August 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04489277.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing